HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $50 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Amylyx Pharma (NASDAQ:AMLX) with a Buy and maintains $50 price target.
HC Wainwright & Co. Reiterates Buy on TRX Gold, Maintains $1.1 Price Target
HC Wainwright & Co. analyst Heiko Ihle reiterates TRX Gold (AMEX:TRX) with a Buy and maintains $1.1 price target.
Needham Reiterates Buy on Airbnb, Maintains $155 Price Target
Needham analyst Bernie McTernan reiterates Airbnb (NASDAQ:ABNB) with a Buy and maintains $155 price target.
EF Hutton Reiterates Buy on Odyssey Marine Explr, Maintains $7.5 Price Target
EF Hutton analyst Michael Albanese reiterates Odyssey Marine Explr (NASDAQ:OMEX) with a Buy and maintains $7.5 price target.
Regional Bank Analyst Slashes Price Targets Across The Board: ‘Interest Rates Pose Significant Risk’
The SPDR S&P 500 ETF Trust (NYSE: SPY) stabilized Monday, but extreme volatility among U.S.
Oracle Likely To Gain Traction In Medium Term Backed By Cloud Momentum, Improving Margins, Analyst Says Post 3Q Results
Mizuho analyst Siti Panigrahi reiterates Buy on Oracle Corp (NYSE:ORCL) with a $116.00 price target. Oracle’s 3Q was driven by substantial cloud…
SVB Collapse Could Materially Impact Coinbase’s Revenue, Profitability Considering USDC’s Criticality To Coinbase, Analyst Says
Mizuho analyst Dan Dolev reiterates Underperform rating on Coinbase Global, Inc (NASDAQ: COIN)
Meta Analyst Estimates Potential Cost Savings From Fresh Round Of Layoffs, Mostly from Metaverse
Mizuho analyst James Lee reiterated Buy on Meta Platforms Inc (NASDAQ:META) with a $210 price target. Several major news outlets indicated that…
Analyst Names Alight As Top Pick, Anticipates Win In Both Strong And Challenging Economy
Needham analyst Kyle Peterson reiterates Alight Inc (NYSE:ALIT) with a Buy and a $13 price target. ALIT’s recent guidance calls for accelerating…
Genius Sports Analysts Highlight Betting Technology Revenue, Long-Term Media Opportunity, NBA Partnership, & More
Needham analyst Bernie McTernan reiterates Genius Sports Ltd (NYSE: GENI)